Cardiac ankyrin repeat protein contributes to dilated cardiomyopathy and heart failure

Cardiac ankyrin repeat protein (CARP) is a cardiac‐specific stress‐response protein which exerts diverse effects to modulate cardiac remodeling in response to pathological stimuli. We examined the role of CARP in postnatal cardiac development and function under basal conditions in mice. Transgenic mice that selectively overexpressed CARP in heart (CARP Tg) exhibited dilated cardiac chambers, impaired heart function, and cardiac fibrosis as assessed by echocardiography and histological staining. Furthermore, the mice had a shorter lifespan and reduced survival rate in response to ischemic acute myocardial infarction. Immunofluorescence demonstrated the overexpressed CARP protein was predominantly accumulated in the nuclei of cardiomyocytes. Microarray analysis revealed that the nuclear localization of CARP was associated with the suppression of calcium‐handling proteins. In vitro experiments revealed that CARP overexpression resulted in decreased cell contraction and calcium transient. In post‐mortem cardiac specimens from patients with dilated cardiomyopathy and end‐stage heart failure, CARP was significantly increased. Taken together, our data identified CARP as a crucial contributor in dilated cardiomyopathy and heart failure which was associated with its regulation of calcium‐handling proteins.

[1]  Aditi Jain,et al.  SIRT2 deacetylase represses NFAT transcription factor to maintain cardiac homeostasis , 2018, The Journal of Biological Chemistry.

[2]  Xin Jiang,et al.  Toll-like receptor 4–induced ryanodine receptor 2 oxidation and sarcoplasmic reticulum Ca2+ leakage promote cardiac contractile dysfunction in sepsis , 2017, The Journal of Biological Chemistry.

[3]  Chen Liu,et al.  Mechanisms contributing to cardiac remodelling. , 2017, Clinical science.

[4]  O. Liew,et al.  Ankyrin Repeat Domain 1 Protein: A Functionally Pleiotropic Protein with Cardiac Biomarker Potential , 2017, International journal of molecular sciences.

[5]  E. Liehn,et al.  Cardiomyocyte Hypertrophy in Arrhythmogenic Cardiomyopathy. , 2017, The American journal of pathology.

[6]  Xinyang Hu,et al.  Cardiac ankyrin repeat protein attenuates cardiomyocyte apoptosis by upregulation of Bcl-2 expression. , 2016, Biochimica et biophysica acta.

[7]  Gary R. Mirams,et al.  Control of NFAT Isoform Activation and NFAT-Dependent Gene Expression through Two Coincident and Spatially Segregated Intracellular Ca2+ Signals , 2016, Molecular cell.

[8]  M. Schipma,et al.  Cardiomyocyte-Specific Ablation of Med1 Subunit of the Mediator Complex Causes Lethal Dilated Cardiomyopathy in Mice , 2016, PloS one.

[9]  Stephan Lange,et al.  MLP and CARP are linked to chronic PKCα signalling in dilated cardiomyopathy , 2016, Nature Communications.

[10]  N. Zhang,et al.  Multifunctional protein: cardiac ankyrin repeat protein , 2016, Journal of Zhejiang University-SCIENCE B.

[11]  C. Lim,et al.  Targeted inhibition of ANKRD1 disrupts sarcomeric ERK-GATA4 signal transduction and abrogates phenylephrine-induced cardiomyocyte hypertrophy. , 2015, Cardiovascular research.

[12]  Y. Liao,et al.  Overexpression of ankyrin repeat domain 1 enhances cardiomyocyte apoptosis by promoting p53 activation and mitochondrial dysfunction in rodents. , 2015, Clinical science.

[13]  J. Čelutkienė,et al.  Induction of Ankrd1 in Dilated Cardiomyopathy Correlates with the Heart Failure Progression , 2015, BioMed research international.

[14]  H. Granzier,et al.  Increased myocardial stiffness due to cardiac titin isoform switching in a mouse model of volume overload limits eccentric remodeling. , 2015, Journal of molecular and cellular cardiology.

[15]  Y. Liao,et al.  Cytosolic CARP Promotes Angiotensin II- or Pressure Overload-Induced Cardiomyocyte Hypertrophy through Calcineurin Accumulation , 2014, PloS one.

[16]  J. Davidson,et al.  ANKRD1 Acts as a Transcriptional Repressor of MMP13 via the AP-1 Site , 2014, Molecular and Cellular Biology.

[17]  A. Marks,et al.  Calcium cycling proteins and heart failure: mechanisms and therapeutics. , 2013, The Journal of clinical investigation.

[18]  Dahai Zhu,et al.  Cardiac Ankyrin Repeat Protein Attenuates Cardiac Hypertrophy by Inhibition of ERK1/2 and TGF-β Signaling Pathways , 2012, PloS one.

[19]  M. Fill,et al.  Abnormal Termination of Ca2+ Release Is a Common Defect of RyR2 Mutations Associated With Cardiomyopathies , 2012, Circulation research.

[20]  R. Knöll,et al.  MLP (muscle LIM protein) as a stress sensor in the heart , 2011, Pflügers Archiv - European Journal of Physiology.

[21]  J. Towbin,et al.  ANKRD1, the gene encoding cardiac ankyrin repeat protein, is a novel dilated cardiomyopathy gene. , 2009, Journal of the American College of Cardiology.

[22]  J. Towbin,et al.  Cardiac ankyrin repeat protein gene (ANKRD1) mutations in hypertrophic cardiomyopathy. , 2009, Journal of the American College of Cardiology.

[23]  H. Zhang,et al.  Upregulated expression of cardiac ankyrin repeat protein in human failing hearts due to arrhythmogenic right ventricular cardiomyopathy , 2009, European journal of heart failure.

[24]  L. Fauchier,et al.  Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy. , 2009, European heart journal.

[25]  X. Wehrens,et al.  NFATc2 Is a Necessary Mediator of Calcineurin-dependent Cardiac Hypertrophy and Heart Failure* , 2008, Journal of Biological Chemistry.

[26]  A. Wilde,et al.  Expanding Spectrum of Human RYR2-Related Disease: New Electrocardiographic, Structural, and Genetic Features , 2007, Circulation.

[27]  S. Houser,et al.  Nuclear Targeting of Akt Enhances Ventricular Function and Myocyte Contractility , 2005, Circulation research.

[28]  Christine E Seidman,et al.  The genetic basis for cardiac remodeling. , 2005, Annual review of genomics and human genetics.

[29]  Christian C Witt,et al.  The muscle ankyrin repeat proteins: CARP, ankrd2/Arpp and DARP as a family of titin filament-based stress response molecules. , 2003, Journal of molecular biology.

[30]  J. Hoheisel,et al.  Cardiac ankyrin repeat protein, a negative regulator of cardiac gene expression, is augmented in human heart failure. , 2002, Biochemical and biophysical research communications.

[31]  R. Nagai,et al.  Cardiac ankyrin repeat protein is a novel marker of cardiac hypertrophy: role of M-CAT element within the promoter. , 2000, Hypertension.

[32]  Jeffrey Robbins,et al.  A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy , 1998, Cell.

[33]  R. Swerlick,et al.  Identification and Characterization of a Novel Cytokine-inducible Nuclear Protein from Human Endothelial Cells (*) , 1995, The Journal of Biological Chemistry.

[34]  P. Caroni,et al.  Muscle LIM protein, a novel essential regulator of myogenesis, promotes myogenic differentiation , 1994, Cell.

[35]  A. Zima,et al.  Functional Impact of Ryanodine Receptor Oxidation on Intracellular Calcium Regulation in the Heart. , 2016, Reviews of physiology, biochemistry and pharmacology.

[36]  Masunori Matsuzaki,et al.  Mechanisms of Disease: ryanodine receptor defects in heart failure and fatal arrhythmia , 2006, Nature Clinical Practice Cardiovascular Medicine.

[37]  Stephan E Lehnart,et al.  Intracellular calcium release and cardiac disease. , 2005, Annual review of physiology.

[38]  P. Hogan,et al.  Transcription factors of the NFAT family: regulation and function. , 1997, Annual review of immunology.